You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. The Persistent Threat of Chronic Inflammation on the Mortality Among Cervical Cancer Survivors: A Mendelian Randomization and Machine Learning Analysis Using UK Biobank and Chinese Cohort Data
- 2. Applications of 3D models in cholangiocarcinoma
- 3. NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer
- 4. NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer
- 5. Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancer
- 6. SHCBP1 drives tumor progression in triple-negative breast cancer
- 7. Bioinformatics-based prognostic value and in vitro functional validation of PTK6 in cutaneous melanoma
- 8. [Latest] Global Lenacapavir Injection Market Size/Share Worth USD 5.68 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- 9. Excess mortality in young cancer survivors compared with the general population in Italy: a retrospective study from the Italian population-based cohort of adolescents and young adult cancer survivors
- 10. Synergistic strategies in photodynamic combination therapy for cancer: mechanisms, nanotechnology, and clinical translation
Last updated at 23:53 GMT
Hot News Makers
Health/Pharma Companies
-
60724.29
-
22802.53
-
22789.62
-
20045.28
-
13108.89
-
9464.13
-
7423.03
-
7222.74
-
6246.79
-
5806.43
Drugs, Treatments, Trials
-
18597.94
-
8475.38
-
5495.85
-
4482.71
-
3813.42
-
3724.93
-
3586.17
-
3071.77
-
2463.59
-
2378.22
Last updated at 23:10 GMT
